Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry.

[1]  M. Mack,et al.  Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial , 2017, JAMA cardiology.

[2]  Eugene Blackstone,et al.  Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes: The STS/ACC TVT Registry. , 2017, Journal of the American College of Cardiology.

[3]  Andrew S. Mugglin,et al.  Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.

[4]  D. Adams,et al.  Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement. , 2016, Journal of the American College of Cardiology.

[5]  Sean M. O'Brien,et al.  GAIT SPEED AND OPERATIVE MORTALITY IN OLDER ADULTS FOLLOWING CARDIAC SURGERY , 2016 .

[6]  Sean M. O'Brien,et al.  Variation in Hospital Risk–Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry , 2016, Circulation. Cardiovascular quality and outcomes.

[7]  Sean M. O'Brien,et al.  Gait Speed and Operative Mortality in Older Adults Following Cardiac Surgery. , 2016, JAMA cardiology.

[8]  J. Spertus,et al.  Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: Insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study. , 2016, American heart journal.

[9]  K. Alexander,et al.  Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry , 2016, Circulation.

[10]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[11]  Sean M. O'Brien,et al.  Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry , 2015, Circulation. Cardiovascular interventions.

[12]  J. Spertus,et al.  Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire , 2015, Circulation. Cardiovascular quality and outcomes.

[13]  D. Adams,et al.  Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial. , 2015, JACC. Cardiovascular interventions.

[14]  Hongyan Qiao,et al.  2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. , 2015, Journal of the American College of Cardiology.

[15]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[16]  J. Spertus,et al.  Clinical Prediction Model Suitable for Assessing Hospital Quality for Patients Undergoing Carotid Endarterectomy , 2014, Journal of the American Heart Association.

[17]  Sean M. O'Brien,et al.  Outcomes following transcatheter aortic valve replacement in the United States. , 2013, JAMA.

[18]  Paul Heidenreich,et al.  Cardiovascular care facts: a report from the national cardiovascular data registry: 2011. , 2013, Journal of the American College of Cardiology.

[19]  Danica Marinac-Dabic,et al.  The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. , 2013, Journal of the American College of Cardiology.

[20]  M. Mack,et al.  Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). , 2013, The American journal of cardiology.

[21]  Adrian F Hernandez,et al.  Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. , 2013, JAMA.

[22]  Sean M. O'Brien,et al.  Report From the Society of Thoracic Surgeons National Database Workforce , 2013, World journal for pediatric & congenital heart surgery.

[23]  J. Spertus,et al.  Use of the Kansas City Cardiomyopathy Questionnaire for Monitoring Health Status in Patients With Aortic Stenosis , 2013, Circulation. Heart failure.

[24]  K. Anstrom,et al.  Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008. , 2012, JACC. Cardiovascular interventions.

[25]  Martin B Leon,et al.  Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). , 2012, Journal of the American College of Cardiology.

[26]  John A Spertus,et al.  Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. , 2010, JAMA.

[27]  K. Stavem,et al.  Reliability and validity of the Kansas City Cardiomyopathy Questionnaire in patients with previous myocardial infarction , 2005, European journal of heart failure.

[28]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.